Vasculitis & polymyalgia rheumatica
The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis
An erratum to this article was published (Rheumatology (Oxford), 4 Feb 2026 ↗)
Methodological detailssystematic literature review, expert consensus, strength of agreement scores, Recommendations updated from the 2014 British Society for Rheumatology (BSR) and BHPR guideline, BSR ANCA-associated vasculitis (AAV) Working Group reviewed published guidelines, undertook a systematic literature review and used expertise from UK specialist vasculitis centres and patient representatives
- Systematic literature review
- Expert consensus
- Strength of agreement scores
- Recommendations updated from the 2014 BSR and BHPR guideline
- BSR AAV Working Group reviewed published guidelines, undertook a systematic literature review and used expertise from UK specialist vasculitis centres and patient representatives
Recommendations
As issued by the authors
Treatment for granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)
Management of subglottic stenosis and ear, nose and throat (ENT) manifestations of AAV
Management and treatment for eosinophilic granulomatosis with polyangiitis (EGPA)
Service specifications
Patient education and support
Original publication
The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis. Rheumatology (Oxford). Published 12 June 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →